Cognition Therapeutics, Inc. - stock earnings
CGTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -6.7 million USD | ? USD |
| 2023Q2 | -4.7 million USD | ? USD |
| 2023Q1 | -3.4 million USD | ? USD |
| 2022Q4 | 11.0 million USD | ? USD |
| 2022Q3 | -625000 USD | ? USD |
| 2022Q2 | -5.8 million USD | ? USD |
| 2022Q1 | -3.8 million USD | ? USD |
| 2021Q4 | -7.3 million USD | ? USD |
| 2021Q3 | -3.1 million USD | ? USD |
| 2021Q2 | -1.5 million USD | ? USD |
| 2021Q1 | 223000 USD | ? USD |
| 2020Q4 | -1.9 million USD | ? USD |
| 2020Q3 | -1.8 million USD | ? USD |
| 2020Q2 | -1.7 million USD | ? USD |
| 2020Q1 | -2.5 million USD | ? USD |
CGTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -22.8 million USD | ? USD |
| 2022 | 757000 USD | ? USD |
| 2021 | -10.3 million USD | ? USD |
| 2020 | -10.1 million USD | ? USD |
| 2019 | -7.0 million USD | ? USD |
CGTX
Price: $1.93
52 week price:
Earnings Per Share: -0.86 USD
P/E Ratio: -2.87
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 239600
Market Capitalization: 74.5 million